- Home
- PCYO vs FENC Comparison
PCYO vs FENC Comparison
Compare PCYO & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- FENC
- Stock Information
- Founded
- PCYO 1976
- FENC 1996
- Country
- PCYO United States
- FENC United States
- Employees
- PCYO N/A
- FENC N/A
- Industry
- PCYO Water Supply
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCYO Utilities
- FENC Health Care
- Exchange
- PCYO Nasdaq
- FENC Nasdaq
- Market Cap
- PCYO 267.7M
- FENC 234.9M
- IPO Year
- PCYO N/A
- FENC 2001
- Fundamental
- Price
- PCYO $11.22
- FENC $8.16
- Analyst Decision
- PCYO
- FENC Strong Buy
- Analyst Count
- PCYO 0
- FENC 2
- Target Price
- PCYO N/A
- FENC $13.50
- AVG Volume (30 Days)
- PCYO 51.3K
- FENC 164.0K
- Earning Date
- PCYO 11-12-2025
- FENC 11-13-2025
- Dividend Yield
- PCYO N/A
- FENC N/A
- EPS Growth
- PCYO 12.50
- FENC N/A
- EPS
- PCYO 0.54
- FENC N/A
- Revenue
- PCYO $26,087,000.00
- FENC $38,790,000.00
- Revenue This Year
- PCYO N/A
- FENC N/A
- Revenue Next Year
- PCYO N/A
- FENC $64.79
- P/E Ratio
- PCYO $20.39
- FENC N/A
- Revenue Growth
- PCYO N/A
- FENC N/A
- 52 Week Low
- PCYO $9.65
- FENC $4.68
- 52 Week High
- PCYO $14.63
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- PCYO 60.70
- FENC 45.64
- Support Level
- PCYO $10.73
- FENC $7.50
- Resistance Level
- PCYO $11.22
- FENC $9.00
- Average True Range (ATR)
- PCYO 0.23
- FENC 0.56
- MACD
- PCYO 0.01
- FENC 0.00
- Stochastic Oscillator
- PCYO 68.59
- FENC 30.90
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.